Table 2.
iNO treatment data and intrahospital patient transportation (Group (2)) data during the ICU stay.
| Group 1∗ (n = 156) | Group 2∗ (n = 65) | P value∗∗ | |
|---|---|---|---|
| Maximal iNO dosage during ICU stay (ppm, mean ± SD) | 35.08 ± 15.618 | 40.95 ± 18.488 | 0.017 |
| iNO dosage during intrahospital transportation (ppm, mean ± SD) | NA | 32.51 ± 14.181 | — |
| iNO treatment length (days, mean ± SD) | 4.5 ± 4.643 | 9.57 ± 10.239 | 0.0001 |
| Duration of intrahospital transportation (minutes, mean ± SD) | NA | 116.89 ± 10.7 | — |
| Intrahospital transport location (%) | |||
| CTa | NA | 52.2% | — |
| Operating room (OR) | NA | 41.8% | — |
| Other (angiography, other intensive care unit) | NA | 6% | — |
| Frequency of intrahospital transportation (%) | |||
| One | NA | 71.6% | — |
| Two | NA | 14.9% | — |
| Three | NA | 4.5% | — |
∗Group 1: critically ill patients who were not transported outside of the ICU during their hospitalization period. Group 2: critically ill patients who were transported outside of the ICU during iNO treatment during their hospitalization period. ∗∗Data are considered statistically significant if P < 0.05.aCT: computerized tomography.